Opportunity
Federal Register #2026-10084
VA Proposed Rule to Expand Access to State Prescription Drug Monitoring Programs
Buyer
Department of Veterans Affairs
Posted
May 20, 2026
Respond By
July 20, 2026
Identifier
2026-10084
The Department of Veterans Affairs (VA) is proposing regulatory changes to improve access to and use of State Prescription Drug Monitoring Programs (PDMPs): - Government Buyer: - Department of Veterans Affairs (VA) - No OEMs or vendors are involved, as this is a regulatory rulemaking, not a procurement - Products/Services Requested: - No products or services are being procured - The rule focuses on information sharing and regulatory definitions - Notable Requirements: - Expands and clarifies who within the VA (including certain contractors) can access and disclose information to State PDMPs - Mandates VA disclosures to State PDMPs to help prevent misuse and diversion of prescription medicines - Preempts conflicting state laws to ensure consistent federal policy - Enhances privacy protections for veterans' medical information - Clarifies statutory definitions such as 'delegate' and 'licensed health care provider' - No purchase quantities, part numbers, or specific technical products are referenced
Description
The Department of Veterans Affairs (VA) proposes amendments to its regulations governing the disclosure of information to and querying of State prescription drug monitoring programs (PDMPs). The rule clarifies statutory definitions, enhances protections for VA personnel, and mandates VA disclosures to prevent misuse and diversion of prescription medicines. It aims to promote safe and effective prescribing of controlled substances for VA patients. Comments on the proposed rule are due by July 20, 2026.